Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,087 | 1,027 | 98.9% |
| Education | $140.72 | 8 | 0.9% |
| Entertainment | $24.90 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,279 | 309 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,193 | 141 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,392 | 104 | $0 (2024) |
| Janssen Biotech, Inc. | $1,315 | 92 | $0 (2024) |
| Celgene Corporation | $528.74 | 34 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $477.64 | 41 | $0 (2024) |
| UCB, Inc. | $455.75 | 28 | $0 (2020) |
| Merck Sharp & Dohme LLC | $388.00 | 27 | $0 (2024) |
| Braintree Laboratories, Inc. | $361.17 | 21 | $0 (2024) |
| Gilead Sciences, Inc. | $337.70 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,756 | 165 | ABBVIE INC. ($799.28) |
| 2023 | $2,231 | 157 | ABBVIE INC. ($554.03) |
| 2022 | $2,202 | 136 | ABBVIE INC. ($689.75) |
| 2021 | $1,919 | 130 | AbbVie Inc. ($520.31) |
| 2020 | $1,355 | 90 | AbbVie Inc. ($494.89) |
| 2019 | $1,807 | 138 | AbbVie, Inc. ($392.04) |
| 2018 | $1,660 | 121 | AbbVie, Inc. ($459.45) |
| 2017 | $1,323 | 100 | AbbVie, Inc. ($368.94) |
All Payment Transactions
1,037 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 12/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Braintree Laboratories, Inc. | SUTAB (Drug), SUFLAVE | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: GI COLON PREP | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $13.03 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/05/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 12/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/03/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: GI | ||||||
| 12/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Immunology | ||||||
| 11/20/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), PLENVU | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $3.87 | General |
| Category: GI | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 11/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $6.46 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 2,362 | 14,321 | $3.8M | $216,960 |
| 2022 | 21 | 2,444 | 13,808 | $3.9M | $201,516 |
| 2021 | 22 | 3,260 | 17,604 | $4.4M | $257,723 |
| 2020 | 23 | 3,179 | 15,745 | $3.9M | $217,680 |
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 43252 | Microscopic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 385 | 429 | $266,838 | $40,864 | 15.3% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 171 | 171 | $528,732 | $29,834 | 5.6% |
| 43250 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using a flexible endoscope with electrical cautery | Facility | 2023 | 141 | 146 | $295,796 | $19,248 | 6.5% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 70 | 71 | $262,274 | $18,387 | 7.0% |
| 46221 | Removal of external hemorrhoids by rubber banding | Facility | 2023 | 48 | 122 | $222,528 | $15,452 | 6.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 135 | 153 | $71,757 | $13,089 | 18.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 133 | 133 | $338,618 | $12,224 | 3.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 251 | 302 | $532,426 | $12,041 | 2.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 174 | 250 | $46,750 | $9,635 | 20.6% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 34 | 35 | $107,835 | $7,889 | 7.3% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 52 | 53 | $141,881 | $7,490 | 5.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 422 | 478 | $742,334 | $7,004 | 0.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $35,217 | $6,914 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 102 | $32,130 | $6,600 | 20.5% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 50 | 63 | $40,698 | $5,001 | 12.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 21 | 21 | $43,764 | $3,477 | 7.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 113 | 11,700 | $46,800 | $1,387 | 3.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 27 | 29 | $2,784 | $423.36 | 15.2% |
| 43252 | Microscopic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 396 | 459 | $285,498 | $42,571 | 14.9% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 190 | 191 | $590,572 | $29,509 | 5.0% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2022 | 95 | 99 | $365,706 | $19,376 | 5.3% |
| 43250 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 125 | 130 | $263,380 | $17,160 | 6.5% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 251 | 317 | $558,871 | $12,344 | 2.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 207 | 308 | $57,596 | $12,165 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 136 | $63,784 | $11,196 | 17.6% |
About Dr. Stephen Matter, M.D
Dr. Stephen Matter, M.D is a Gastroenterology healthcare provider based in Normal, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134228224.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Matter, M.D has received a total of $15,253 in payments from pharmaceutical and medical device companies, with $2,756 received in 2024. These payments were reported across 1,037 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($15,087).
As a Medicare-enrolled provider, Matter has provided services to 11,245 Medicare beneficiaries, totaling 61,478 services with total Medicare billing of $893,879. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Normal, IL
- Active Since 09/22/2006
- Last Updated 08/14/2008
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1134228224
Products in Payments
- XIFAXAN (Drug) $1,984
- RINVOQ (Biological) $665.04
- Humira (Biological) $649.75
- REMICADE (Biological) $630.88
- LINZESS (Drug) $577.38
- HUMIRA (Biological) $548.99
- STELARA (Biological) $534.89
- ENTYVIO (Biological) $518.00
- ZEPOSIA (Drug) $512.20
- VIBERZI (Drug) $465.63
- Cimzia (Drug) $455.75
- Linzess (Drug) $373.44
- CREON (Drug) $363.27
- MAVYRET (Drug) $358.87
- SKYRIZI (Biological) $342.81
- TREMFYA (Drug) $316.13
- Creon (Drug) $307.07
- ZENPEP (Drug) $292.56
- Entyvio (Biological) $261.66
- CLENPIQ (Drug) $234.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Normal
Mr. Thomas Deweert, Md, MD
Gastroenterology — Payments: $3,170
Mr. Philip Koszyk, Md, MD
Gastroenterology — Payments: $2,743
Harris Siddiqui, Md, MD
Gastroenterology — Payments: $694.56
Anzhelika Grzesiak, Aprn, Fnp-C, APRN, FNP-C
Gastroenterology — Payments: $278.27
Mr. Herbert Wiser, Md, MD
Gastroenterology